Inspira™ art100 receives fda 510(k) clearance

Ra'anana, israel , may 28, 2024 /prnewswire/ -- inspira™ technologies oxy b.h.n. ltd. (nasdaq: iinn) (nasdaq: iinnw) (the "company", "inspira", or "inspira technologies"), a breakthrough medical technology company, today announced that it has received notification of 510(k) class ii clearance from the u.s. food and drug administration (fda) for its inspira™ art100, a cardiopulmonary bypass system.
IINN Ratings Summary
IINN Quant Ranking